All In Biotech

Drug Trial Radar · NCT05399641

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

Oral Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis (VVC) in Subjects Who Have Failed Fluconazole Therapy

Last checked: Nov 20, 2026Latest source record: Jul 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

150

Actual

Start

May 1, 2022

Primary completion

May 16, 2023

Study completion Aug 2, 2023

Sponsor

Lead sponsor
Scynexis, Inc.Industry
Sponsor type
Industry
First posted
Jun 1, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will treat subjects with complicated VVC who have failed prior fluconazole therapy with Ibrexafungerp for 1, 3 or 7 days of treatment.

Conditions

  • Vulvovaginal Candidiasis

Interventions

  • IbrexafungerpDrug

    Each day dosing will consist of two 150mg tablets taken BID.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical CureTime frame: 14 days post-Baseline - Test-Of-Cure (TOC)

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Precision Trials, AZ

    Phoenix, Arizona

  • Women's Healthcare Research

    San Diego, California

  • Wake Research (MCCR)

    San Diego, California

  • New Age Medical Research

    Miami, Florida

  • Wake (Mount Vernon Clinical Research)

    Atlanta, Georgia

  • Clinical Research Prime

    Idaho Falls, Idaho

  • Leavitt Women's Healthcare

    Idaho Falls, Idaho

  • Women Under Study

    New Orleans, Louisiana

  • Massachusetts's General

    Boston, Massachusetts

  • Wayne State University

    Detroit, Michigan

  • Consultants in Women's Healthcare

    St Louis, Missouri

  • Wake Research (CRCN)

    Las Vegas, Nevada

  • Capital Health Lawrence OBGYN

    Lawrenceville, New Jersey

  • Center for Colposcopy

    Lake Success, New York

  • Wake Research (Carolina Institute for Clinical Research)

    Fayetteville, North Carolina

  • UWCR - Raleigh

    Raleigh, North Carolina

  • Lyndhurst Clinical Research

    Winston-Salem, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Oregon Health and Science University

    Portland, Oregon

  • Jefferson University

    Philadelphia, Pennsylvania

  • Medical Research Center

    Memphis, Tennessee

  • Discovery Clinical Trials

    Dallas, Texas

  • TMC Life Research, Inc

    Houston, Texas

  • Discovery Clinical Trials

    McAllen, Texas

  • Seattle Clinical Research Center

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.